ANIEKAN UKPANAH APPOINTED CHAIRMAN OF LEX MUNDI’S BOARD OF DIRECTORS
We are incredibly proud to share a historic milestone for Udo Udoma & Belo-Osagie: our Senior Partner, Aniekan Ukpanah, has been appointed Chairman of the
May 12, 2025
We are incredibly proud to share a historic milestone for Udo Udoma & Belo-Osagie: our Senior Partner, Aniekan Ukpanah, has been appointed Chairman of the
On 29 March 2025, the President of the Federal Republic of Nigeria, President Bola Ahmed Tinubu, signed the Investment and Securities Act 2025 into law.
Nigeria’s healthcare sector is embracing digital innovation, with services like telemedicine, e-pharmacies and mobile health platforms gaining acceptance. While these tools promise improved access and
As part of our ongoing collaboration with the Private Equity Women Investor Network (PEWIN), we are pleased to announce our sponsorship of the Convene Africa
What opportunities and challenges does digital healthcare present in Nigeria’s regulatory environment? Udo Udoma & Belo-Osagie invites you to join our upcoming webinar examining the
UUBO is pleased to have contributed to the Corporate Tax (Trends & Developments) Global Practice Guide 2025 published by Chambers and Partners. In this contribution,
We at Udo Udoma & Belo-Osagie (UUBO) are pleased to have contributed to the latest edition of Legal 500’s “Doing Business In: Nigeria – Country
Nigeria Data Protection Commission Issues GAID 2025 On March 20, 2025, the Nigeria Data Protection Commission (NDPC) released the General Application and Implementation Directive 2025
We are bursting with pride to announce that our outstanding Banking & Finance, Capital Markets, Fintech, and Pro Bono teams Partner, Yinka Edu, has been
We at Udo Udoma & Belo-Osagie are pleased to share that our work on the CrossBoundary Energy financing transaction has been awarded Deal of the
Please take a moment to review our Privacy Policy. It explains how we collect, use, and protect your personal data in accordance with the Nigeria Data Protection Act 2023.
By clicking “Continue,” you acknowledge that you have read and understood our Privacy Policy.
If we require your consent for specific data uses (e.g., direct marketing, cross-border data transfer or profiling), we will ask for it separately.